BIOTECH TARGET N V

Average Profitability
<0.0001%
Insider Buys Quantity
51
Insider Buys Sum
$114.74M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of BIOTECH TARGET N V

The largest purchase of all time was on 2021-09-16 and amounted to 400000 shares of MacroGenics, Inc. for $8.38M.

Biography of BIOTECH TARGET N V

No biography is available at this moment.

2023-10-02PurchaseMacroGenics, Inc.
MGNX
10 percent owner
150,000
0.2413%
$4.46$669,585+42.19%
2023-09-07PurchaseMacroGenics, Inc.
MGNX
10 percent owner
200,000
0.324%
$5.26$1.05M+20.64%
2023-02-14PurchaseMacroGenics, Inc.
MGNX
10 percent owner
500,000
0.7819%
$5.07$2.53M+15.84%
2023-01-19PurchaseMacroGenics, Inc.
MGNX
director
150,000
0.245%
$5.30$794,925+10.1%
2022-12-27PurchaseMacroGenics, Inc.
MGNX
director
200,000
0.3249%
$5.61$1.12M+1.25%
2022-12-23PurchaseMacroGenics, Inc.
MGNX
director
200,000
0.3225%
$5.88$1.18M-4.55%
2022-11-22PurchaseMacroGenics, Inc.
MGNX
director
300,000
0.471%
$5.96$1.79M-7.93%
2022-10-24PurchaseMacroGenics, Inc.
MGNX
director
250,000
0.4034%
$4.36$1.09M+29.32%
2022-10-21PurchaseMacroGenics, Inc.
MGNX
director
250,000
0.3924%
$4.63$1.16M+18.65%
2022-10-20PurchaseMacroGenics, Inc.
MGNX
director
285,977
0.4631%
$4.00$1.14M+41.54%
2022-10-19PurchaseMacroGenics, Inc.
MGNX
director
168,422
0.2659%
$3.70$623,919+48.95%
2022-05-18PurchaseRadius Health, Inc.
RDUS
10 percent owner
477,824
0.4823%
$5.57$2.66M-11.82%
2022-01-06PurchaseRadius Health, Inc.
RDUS
10 percent owner
300,000
0.3433%
$6.31$1.89M-22.32%
2022-01-05PurchaseRadius Health, Inc.
RDUS
10 percent owner
250,000
0.2854%
$6.30$1.57M-32.62%
2021-11-19PurchaseMacroGenics, Inc.
MGNX
10 percent owner
200,000
0.3261%
$18.50$3.7M-72.08%
2021-09-29PurchaseMacroGenics, Inc.
MGNX
10 percent owner
100,000
0.1634%
$20.47$2.05M-57.83%
2021-09-29PurchaseRadius Health, Inc.
RDUS
10 percent owner
100,000
0.2346%
$12.95$1.29M+0.23%
2021-09-28PurchaseMacroGenics, Inc.
MGNX
10 percent owner
100,000
0.1636%
$20.64$2.06M-57.9%
2021-09-22PurchaseRadius Health, Inc.
RDUS
10 percent owner
150,000
0.3337%
$12.28$1.84M+6.81%
2021-09-17PurchaseMacroGenics, Inc.
MGNX
10 percent owner
200,000
0.3182%
$19.93$3.99M-56.4%
Total: 51
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.